313 related articles for article (PubMed ID: 29663885)
1. Liposomes as a Promising Ultrasound-Triggered Drug Delivery System in Cancer Treatment.
Salkho NM; Turki RZ; Guessoum O; Martins AM; Vitor RF; Husseini GA
Curr Mol Med; 2017; 17(10):668-688. PubMed ID: 29663885
[TBL] [Abstract][Full Text] [Related]
2. The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes.
Ahmed SE; Martins AM; Husseini GA
J Drug Target; 2015 Jan; 23(1):16-42. PubMed ID: 25203857
[TBL] [Abstract][Full Text] [Related]
3. Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy.
Kumar P; Gulbake A; Jain SK
Crit Rev Ther Drug Carrier Syst; 2012; 29(5):355-419. PubMed ID: 22876808
[TBL] [Abstract][Full Text] [Related]
4. Ultrasonically triggered drug delivery: breaking the barrier.
Husseini GA; Pitt WG; Martins AM
Colloids Surf B Biointerfaces; 2014 Nov; 123():364-86. PubMed ID: 25454759
[TBL] [Abstract][Full Text] [Related]
5. Ultrasonic drug delivery in Oncology.
Udroiu I
J BUON; 2015; 20(2):381-90. PubMed ID: 26011326
[TBL] [Abstract][Full Text] [Related]
6. Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review.
Tanbour R; Martins AM; Pitt WG; Husseini GA
Curr Pharm Des; 2016; 22(19):2796-807. PubMed ID: 26898742
[TBL] [Abstract][Full Text] [Related]
7. Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy.
Moosavian SA; Bianconi V; Pirro M; Sahebkar A
Semin Cancer Biol; 2021 Feb; 69():337-348. PubMed ID: 31585213
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review.
Mukhopadhyay D; Sano C; AlSawaftah N; El-Awady R; Husseini GA; Paul V
Recent Pat Anticancer Drug Discov; 2021; 16(4):498-520. PubMed ID: 34911412
[TBL] [Abstract][Full Text] [Related]
9. Liposomes in Active, Passive and Acoustically-Triggered Drug Delivery.
Basha SA; Salkho N; Dalibalta S; Husseini GA
Mini Rev Med Chem; 2019; 19(12):961-969. PubMed ID: 30961495
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: From theoretical considerations to practical applications.
Boissenot T; Bordat A; Fattal E; Tsapis N
J Control Release; 2016 Nov; 241():144-163. PubMed ID: 27667179
[TBL] [Abstract][Full Text] [Related]
11. Tumor Microenvironment-Sensitive Liposomes Penetrate Tumor Tissue via Attenuated Interaction of the Extracellular Matrix and Tumor Cells and Accompanying Actin Depolymerization.
Suzuki S; Itakura S; Matsui R; Nakayama K; Nishi T; Nishimoto A; Hama S; Kogure K
Biomacromolecules; 2017 Feb; 18(2):535-543. PubMed ID: 28055201
[TBL] [Abstract][Full Text] [Related]
12. Review on triggered liposomal drug delivery with a focus on ultrasound.
Moussa HG; Martins AM; Husseini GA
Curr Cancer Drug Targets; 2015; 15(4):282-313. PubMed ID: 25760762
[TBL] [Abstract][Full Text] [Related]
13. Targeted Delivery of Bleomycin: A Comprehensive Anticancer Review.
Yu Z; Yan B; Gao L; Dong C; Zhong J; D Ortenzio M; Nguyen B; Seong Lee S; Hu X; Liang F
Curr Cancer Drug Targets; 2016; 16(6):509-21. PubMed ID: 26632436
[TBL] [Abstract][Full Text] [Related]
14. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
Zhang J; Tang H; Liu Z; Chen B
Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
[TBL] [Abstract][Full Text] [Related]
15. Surface-active liposomes for targeted cancer therapy.
Sofou S
Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
[TBL] [Abstract][Full Text] [Related]
16. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
17. Evaluation the Anti-Cancer Effect of PEGylated Nano-Niosomal Gingerol, on Breast Cancer Cell lines (T47D), In-Vitro.
Behroozeh A; Mazloumi Tabrizi M; Kazemi SM; Choupani E; Kabiri N; Ilbeigi D; Heidari Nasab A; Akbarzadeh Khiyavi A; Seif Kurdi A
Asian Pac J Cancer Prev; 2018 Mar; 19(3):645-648. PubMed ID: 29580033
[TBL] [Abstract][Full Text] [Related]
18. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
19. Stimuli-responsive Smart Liposomes in Cancer Targeting.
Jain A; Jain SK
Curr Drug Targets; 2018 Feb; 19(3):259-270. PubMed ID: 26853324
[TBL] [Abstract][Full Text] [Related]
20. [Delivery in hypoxic tumor regions of a chemotherapeutic agent encapsulated in nanoliposomes carried by magnetoaerotactic bacteria].
Felfoul O; Mohammadi M; Taherkhani S; de Lanauze D; Zhong Xu Y; Lafleur M; Gaboury L; Tabrizian M; Vuong T; Batist G; Beauchemin N; Radzioch D; Martel S
Med Sci (Paris); 2018 Mar; 34(3):197-199. PubMed ID: 29547100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
